E-viri
Odprti dostop
-
López-Padilla, Daniel; Terán-Tinedo, José; Cerezo-Lajas, Alicia; García, Laura Ramírez; Ojeda-Castillejo, Elena; López-Martín, Soledad; Diaz-Cambriles, Trinidad; Virseda, Sonia González; Melgar, Begoña Arias; Pizarro, Ana Candel; Alcocer, Héctor Lozano; Troncoso-Acevedo, María Fernanda; García, Teresa Gómez; Yeste, Pablo López; Cano-Pumarega, Irene; García-Sánchez, Aldara; Arcos, Beatriz Arias; García, Enrique Zamora; Rodríguez, Pedro Landete; Iturricastillo, Gorane; Lores Gutiérrez, Vanesa; Alonso, Carlos Rodríguez; Ortola, Martha Vidal; López-Riolobos, Cristina; García-Prieto, Fernando; Abad-Fernández, Araceli; Baena, Eva Mañas
Journal of clinical sleep medicine, 2022-Feb-01, 2022-02-00, 20220201, Letnik: 18, Številka: 2Journal Article
Obstructive sleep apnea (OSA) has been associated with cardiovascular events (CVEs), although recent randomized controlled trials have not demonstrated that long-term continuous positive airway pressure (CPAP) prevents CVEs. Our objective was to determine the effect of CPAP on older adults with moderate OSA regarding CVE reduction. An observational and multicenter study of a cohort of older adults (> 70 years of age) diagnosed with moderate OSA (apnea-hypopnea index 15.0-29.9 events/h) was conducted. Two groups were formed: (1) CPAP treatment and (2) standard of care. The primary endpoint was CVE occurrence after OSA diagnosis. Association with CPAP treatment was assessed by propensity score matching and inverse weighting probability. Secondary endpoints were incidence of CVE separately and time to first CVE. A total of 614 patients were included. After matching, 236 older adults (111 men, mean age 75.9 ± 4.7 years) with a follow-up of 47 months (interquartile range: 29.6-64.0 months) were considered for primary and secondary endpoint evaluations. Forty-one patients presented at least 1 CVE (17.4%): 20 were in the standard-of-care group (16.9%) and 21 were in the CPAP group (17.8%), with a relative risk of 1.05 (95% confidence interval CI, 0.60-1.83; = .43) for CPAP treatment. Inverse probability weighting of the initial 614 patients determined an adjusted relative risk of 1.24 (95% CI, 0.79-1.96; = .35) for CPAP treatment. No statistical differences were found in secondary endpoint analyses. CPAP should not be prescribed to reduce CVE probability in older adults with moderate OSA. López-Padilla D, Terán-Tinedo J, Cerezo-Lajas A, et al. Moderate obstructive sleep apnea and cardiovascular outcomes in older adults: a propensity score-matched multicenter study (CPAGE-MODE study). . 2022;18(2):553-561.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.